HTL0039732 Capsules and atezolizumab infusion clinical trials

HTL0039732 in Participants With Advanced Solid Tumours

This study is testing a new drug, HTL0039732, alone and with another cancer medicine, atezolizumab. It's for people with advanced solid tumours, aiming to see if blocking certain signals can help the immune system fight cancer. The goal is to find the right dose and see how well it works.